This is the billion dollar question. Or at least was, before the company started going down the drain<p>The <i>only</i> person that had some knowledge of biology on board was Holmes. Now, while the board usually doesn&#x27;t deal with the technical minutia they should be definitely keeping an eye on possible regulatory needs and associated risks